Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell TherapiesRebecca A Gardner, Claire White, Magdi Elsallab, et al.
Cytotherapy|May 31, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumorsAnne Miller, Rachel Daum, Tao Wang, et al.
Transplantation and Cellular Therapy|September 14, 2024
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Pediatric Blood & Cancer|January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid TumorsAaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Haematologica|October 20, 2022
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemiaAlan S Wayne, Van Huynh, Nobuko Hijiya, et al.
Blood|December 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomasLaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm populationJonathan E Brammer, Alexander Stentz, James Gajewski, et al.
Blood Reviews|July 7, 2026
What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapySanghee Hong, Manuel Ricardo Espinoza-Gutarra, Rahul Shah, et al.
Blood Advances|June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registrySamuel John, Kevin J Curran, Erin M Hall, et al.
Pageof 7